Clincosm LogoSign in Get a demo

prostatic neoplasms

Showing NaN - NaN of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostatic Tumors, Prostate Cancer Trial in United Kingdom, United States (Abiraterone acetate, Prednisone)

Completed
Has Results
  • Prostatic Neoplasms
  • Prostate Cancer
  • Los Angeles, California
  • +13 more
Jun 25, 2013

Prostatic Tumors Trial in Worldwide (CP-751,871, docetaxel, prednisone)

Completed
Has Results
  • Prostatic Neoplasms
  • Los Angeles, California
  • +17 more
Mar 5, 2013

Prostatic Tumors Trial in Worldwide (Prednisone, sunitinib, Placebo)

Terminated
Has Results
  • Prostatic Neoplasms
  • Decatur, Alabama
  • +204 more
Feb 5, 2013

Prostatic Tumors, Multiple Myeloma, Bladder Tumors Trial in United States (Gallium maltolate)

Terminated
  • Prostatic Neoplasms
  • +3 more
  • Gallium maltolate
  • Springdale, Arkansas
  • +4 more
Jan 21, 2011

Prostatic Tumors Trial in United States (VELCADE TM (bortezomib) for Injection)

Completed
  • Prostatic Neoplasms
  • VELCADE TM (bortezomib) for Injection
  • Los Angeles, California
  • +3 more
Feb 7, 2008

Prostatic Tumors Trial in New York (Samarium Sm-153 lexidronam + Docetaxel)

Unknown status
  • Prostatic Neoplasms
  • Samarium Sm-153 lexidronam + Docetaxel
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Dec 17, 2007

Prostatic Tumors Trial in Worldwide (Atrasentan)

Completed
  • Prostatic Neoplasms
  • Homewood,, Alabama
  • +233 more
Aug 13, 2007

Prostatic Tumors Trial in New York, Durham, Cleveland (MLN2704 (DM1 conjugated mAb MLN591))

Completed
  • Prostatic Neoplasms
  • MLN2704 (DM1 conjugated monoclonal antibody MLN591)
  • New York, New York
  • +3 more
Jul 12, 2007

Prostatic Tumors Trial in New York (Monoclonal Antibody J591, Recombinant Interleukin-2)

Completed
  • Prostatic Neoplasms
  • Monoclonal Antibody J591
  • Recombinant Interleukin-2
  • New York, New York
    New York Presbyterian Hospital Medical Oncology/Urology Clinics
Jan 19, 2007